Patients

Education & Access

Find a Theranostic Clinical Trial Right for You!
Ability to Contact Expert Theranostic Oncologists
Education to better understand Radiation
Education to better understand Theranostics
Education to better understand Clinical Trials

Along with specific trial information. TheranosticTrials.org contains much easy-to-understand background information on what is Theranostics, what is radiation, and dispelling many of the myths and misconceptions of clinical trials.

Search for Trials by Cancer Type

Adrenal Gland/Adrenocortical Basket Trials (Multiple Types)Biliary Tract/Gall Bladder/Cholangiocarcinoma (GI)Bladder/Urothelial (GU)Bone Metastases Brain and Central Nervous System (CNS)Breast Cervical (GYN)Colon/Rectal/Anal (GI)Endocrine Cancers Endocrine Neoplasia Esophageal (GI)Gastric/Stomach (GI)Gastrointestinal (GI) (Multiple Types)General Solid Tumors (Multiple Types)GenitoUrinary (GU) (Multiple Types)GEP-NET (NEC)GI Stromal Tumor (GIST)Gynecologic (GYN) (Multiple Types)Head and Neck Cancers Hepatocellular/Liver (GI)Hodgkins Lymphoma Insulinoma Kidney/Renal Cell Carcinoma (GU)Leukemias Lung Lymphomas Melanoma/Skin Cancers Mesothelioma Multiple Myeloma NeuroBlastoma NeuroEndocrine (NEC) (Multiple Types)NeuroEndocrine Carcinoma (NEC)Osteosarcoma Ovarian Ovarian/Primary Peritoneal (GYN)Pancreatic (GI)Paraganglioma (NEC)Penile (GU)Pheochromocytoma (NEC)Pituitary Prostate (GU)Salivary Gland Sarcoma Synovial Carcinoma Testicular (GU)Thymoma Thyroid Unknown Primary Cancers Uterine (GYN)Vulvar (GYN)

Distinguished Investigator

A Distinguished Investigator of Theranostics is a level of distinction conferred upon an individual physician who has demonstrated a mastery of conducting novel radioligand therapies and molecular imaging clinical trials.

Luke T. Nordquist, MD

Dr. Luke Nordquist is a Medical Oncologist with an expertise in Prostate Cancer. He is the Founder and CEO of XCancer® in Omaha, NE. Dr. Luke and the XCancer® team are globally recognized for their many contributions to the advancement of novel imaging and therapies for prostate cancer. The XCancer® team are often considered as a go to site for rapid startup, phase 1 trials because of their focus, quality and exceptional efficiency. XCancer® has the ability to open a clinical trial in a few weeks. As of 2024, Dr. Luke and his team have accrued more than 1500 patient to clinical trials and conducted more than 20 First-in-World clinical trials for Prostate Cancer. They have extensive experience with many radioisotopes having conducted more than 40 radiopharmaceutical imaging and therapeutic trials. His team accrued the first patient, the most patients and had the highest quality data on the Lu177 PSMA Vision Trial. More than 450 prostate cancer patients every month from more than 40 states and several countries travel to Dr. Luke in Omaha for their prostate cancer care. To improve education, awareness, and access to radiopharmaceutical clinical trials globally, Dr. Luke developed TheranosticTrials.org. XCancer® also has developed a strategic program, business knowledge, and training curriculum to assist other Medical Oncologists & Community Cancer Centers from coast to coast in developing radiopharmaceutical programs that are able to conduct early to late phase clinical trials. XCancer® is helping assist cancer care as far away as Tanzania, Africa. The XCancer® Foundation, funded the construction of a cancer housing hostel at the Kilimanjaro Christian Medical Center (KCMC) in Moshi, Tanzania. Omaha, NE USA Contact Information: For Patient Appointments: Patient Advocate Desk: 402-991-8468 For Clinical Trials: Tony Romero 402-991-8468 For Industry/Business Meetings: Stacy Moore 402-991-8468 drluke@xcancer.com

About Us

TheranosticTrials was developed through the collaboration of 2 key opinion leaders in the field of Radiopharmaceuticals. Drs. Luke Nordquist and Oliver Sartor saw the need for a such a web-based tool to provide patient education & ultimately improve access to the rapidly expanding field of radiopharmaceutical clinical trials. Patients globally are seeking access to these highly sought-after clinical trials which are providing new hope.

Education

Learn More About How Radiation Works

Learn More About How Theranostics Work

Learn More About Clinical Trials

Dictionary of Theranostic Terms

Learn More About Disparities

RLT Components

RADIOLIGAND THERAPY (RLT) is a highly effective approach to very accurately locating cancer cells and effectively killing those same cells by delivery various radioisotopes to a specific target that is located on a type of cancer. Some of the Radioisotopes are diagnostic for locating cancers & some therapeutic to treat the cancers.

There are several Components to a RLT that are simply demonstrated in the truck diagram including:

Cancer Targets
Ligand (demonstrated as the Truck GPS set to find a specific Target)
Diagnostic Radioisotopes (demonstrated as light bulbs that light the cancer Targets on a PET scan)
Therapeutic Radioisotopes (demonstrated as bombs that kill cancer cells that express the target with either Alpha or Beta radiation)
Linker (demonstrated as the hitch keeping the Radioisotope attached to the Ligand)
Chelator (demonstrated as the Trailers which keeps the Radioisotope on Target).

To learn more about the specific components being studied today on clinical trials around the world check out the RLT COMPONENTSTab.

View RLT Components